Healthcare / Medical DistributionSaudi
$74.75
+0.25 (+0.33%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 32% · confianza 25%
FCF escenarios
weak_data · normalized FCF $7.6M · quality 56.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
56/100
C
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$523M
P/E
11.2x
↓EV/EBITDA
9.6x
↓ROE
28.6%
↑Gross Margin
41.1%
↓Debt/Equity
0.01
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2021–2024 · 3 años de histórico normalizado
Revenue CAGR
+17.9%
FCF CAGR
—
FCF margin
-1.6%
FCF / Net income
-0.09x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $248.4M · net income $45.4M · FCF $-4.1M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $248.4M | $248.4M | $220.0M | $193.2M | $151.4M |
| Net Income | $45.4M | $45.4M | $33.5M | $26.7M | $21.2M |
| EBITDA | $52.5M | $52.5M | $39.8M | $31.2M | $24.9M |
| EPS | 6.49 | 6.49 | 4.79 | 3.81 | 3.03 |
| Gross Margin | 41.1% | 41.1% | 43.4% | 46.7% | 45.9% |
| Operating Margin | 18.2% | 18.2% | 15.1% | 15.5% | 16.2% |
| Net Margin | 18.3% | 18.3% | 15.2% | 13.8% | 14.0% |
| Balance Sheet | |||||
| Debt/Equity | 0.01 | 0.01 | 0.02 | 0.01 | 0.02 |
| Current Ratio | 3.28 | 3.28 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-4.1M | $-4.1M | $34.7M | $7.6M | $20.3M |
| Returns | |||||
| ROE | 28.6% | 28.6% | 26.4% | 24.9% | 22.7% |
| Valuation | |||||
| P/E | 11.23 | 11.23 | 10.58 | 9.48 | — |
| EV/EBITDA | 9.57 | 9.57 | 7.90 | 7.38 | — |
| P/B | 3.31 | 3.31 | 2.79 | 2.35 | — |
| Growth & Yield | |||||
| Revenue Growth | 12.9% | 12.9% | 13.9% | 27.6% | — |
| EPS Growth | 35.5% | 35.5% | 25.7% | 25.7% | — |
| Dividend Yield | 2.6% | 2.6% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
0.7%
EPS terminal req.
$6.63
Spread vs growth
34.8%
5Y implied EPS CAGR
4.3%
EPS terminal req.
$8.03
Spread vs growth
31.2%
10Y implied EPS CAGR
7.1%
EPS terminal req.
$12.93
Spread vs growth
28.4%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-30.9%
Start / end P/E
23.5x → 11.6x
EPS bridge
4.79 → 6.49
Residual
-18.1%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.